Improving Access to Influenza Testing and Treatment: Is It Time for Over-the-counter Oseltamivir? - Takeaways - MDSpire

Improving Access to Influenza Testing and Treatment: Is It Time for Over-the-counter Oseltamivir?

  • By

  • Kyueun Lee

  • Andrew T Pavia

  • Janet A Englund

  • October 17, 2025

  • 0 min

Share

  • 1

    Oseltamivir, an antiviral for influenza, is being considered for over-the-counter status to improve access to treatment.

  • 2

    Timely administration of oseltamivir can reduce illness duration and complications when given within 48 hours of symptom onset.

  • 3

    Antiviral underutilization is prevalent, with only 20% of patients with influenza-like illnesses receiving prescriptions.

  • 4

    Improved access to oseltamivir could enhance public health responses during seasonal outbreaks and potential pandemics.

  • 5

    Rapid influenza testing combined with OTC oseltamivir could alleviate pressure on healthcare facilities and reduce viral transmission.

Original Source(s)

Improving Access to Influenza Testing and Treatment: Is It Time for Over-the-counter Oseltamivir?

  • by Kyueun Lee, Andrew T Pavia, Janet A Englund

  • October 17, 2025

Related Content

Flu Vaccine Cut Hospitalizations Despite Drifted H3N2 Strain

Interim CDC estimates found the 2025–2026 vaccine reduced outpatient influenza visits by up to 41% and hospitalizations by up to 41%.

Prevalence and determinants of fever, diarrhea, and acute respiratory infection among children aged 5–59 months in Somaliland, 2020: insights from a nationwide survey

Advancements in Intranasal Influenza Vaccines: Mechanisms, Platforms, and Progress in Translation